Products

Lung Vision
BODY VISION MEDICAL
Oncology AI
LungVision by Body Vision Medical is an AI-powered, intraoperative imaging system that converts 2D C-arm images into real-time 3D views for precise navigation and visual confirmation during lung biopsies, enhancing early lung cancer detection and treatment.
Lung Vision System
Body Vision Medical
Oncology AI
The LungVision® System is an AI-powered, intraoperative imaging and navigation system from Body Vision Medical that transforms 2D C-arm images into real-time 3D for precise peripheral lung biopsy and intervention. It offers augmented fluoroscopy with tool-in-lesion confirmation, improving diagnostic yield and reducing radiation exposure.

See all 2 products →

About Body Vision Medical

Body Vision Medical is a healthcare AI company dedicated to revolutionizing the diagnosis and treatment of lung cancer through its advanced LungVision® system. This proprietary AI-powered intraoperative imaging platform transforms standard 2D C-arm X-ray images into real-time 3D visualizations, effectively providing “X-ray vision” for pulmonary interventionalists. The system addresses a critical challenge in bronchoscopic procedures by correcting for CT-to-body divergence, which often leads to discrepancies between pre-operative CT scans and the actual lesion location during biopsy. By enabling visual confirmation of tool-in-lesion, LungVision empowers bronchoscopists to accurately locate and biopsy smaller, more difficult-to-access lung lesions with enhanced precision and confidence, ultimately improving diagnostic yields and facilitating earlier lung cancer detection.

Beyond diagnostics, Body Vision Medical’s technology is also poised to support minimally invasive therapeutic interventions. The LungVision platform aims to streamline the entire pulmonary nodule workflow, offering a cost-effective solution that integrates seamlessly with existing equipment while significantly reducing radiation exposure compared to traditional 3D systems. This comprehensive approach, backed by a commitment to continuous innovation, seeks to set a new standard of care for lung diagnostics and therapies, making cutting-edge interventions more accessible globally.

What Physicians Need to Know

Specialization
Body Vision Medical specializes in AI-driven, intraoperative CT imaging for lung cancer diagnostics and therapies. Their flagship LungVisionu00ae System transforms images from any 2D C-arm into real-time 3D images for navigation bronchoscopy procedures, focusing on early, definitive lung cancer diagnosis and minimally-invasive treatment of lung lesions.
Key Differentiators
Body Vision Medical's proprietary AI Tomou00ae technology is a key differentiator, providing near-cone beam CT quality 3D imaging using conventional 2D C-arms, which significantly reduces radiation dose (approximately 1/5 of a 3D C-arm scan) and cost. The system offers real-time, intraoperative visual confirmation of tool-in-lesion, effectively correcting for CT-to-body divergence. It boasts high diagnostic yields, approaching 90% and beyond, and is a hardware-light, affordable solution designed for seamless integration with existing bronchoscopy equipment.
Technology Stack
The core of Body Vision Medical's technology stack relies on Artificial Intelligence (AI) and proprietary algorithms, including AI Tomou00ae and C-Arm Based Tomography (CABT) technology. This software-driven system performs multimodal image fusion of preoperative CT scans and real-time intraoperative fluoroscopy to transform 2D X-ray images into advanced 3D visualizations. The system is wirelessly controlled via a tablet for planning and procedure management.
Physician Tip

For physicians, Body Vision Medical's LungVision system offers enhanced diagnostic confidence and accuracy by providing real-time, intraoperative 3D imaging and visual tool-in-lesion confirmation. This capability allows for precise navigation and biopsy of even small and peripheral lung lesions, leading to significantly improved diagnostic yields and earlier, more definitive lung cancer diagnoses. The system helps reduce patient radiation exposure and can shorten procedural duration. Its cost-effectiveness, by leveraging existing C-arms, makes advanced imaging more accessible. Furthermore, it effectively addresses the critical challenge of CT-to-body divergence, ensuring that the actual lesion location is accurately targeted.

The LungVision system is designed for seamless integration with existing standard bronchoscopy suite equipment. This includes compatibility with 2D and 3D C-arms, various navigation platforms, conventional and robotic bronchoscopes, and a wide range of biopsy tools (e.g., cryoprobes). Its modular design allows it to function as a dedicated intraoperative 3D imaging system for tool-in-lesion confirmation or as a standalone navigational bronchoscopy platform.

Products by Body Vision Medical

2 products in the directory

Lung Vision
BODY VISION MEDICAL
Oncology AI
LungVision by Body Vision Medical is an AI-powered, intraoperative imaging system that converts 2D C-arm images into real-time 3D views for precise navigation and visual confirmation during lung biopsies, enhancing early lung cancer detection and treatment.
Lung Vision System
Body Vision Medical
Oncology AI
The LungVision® System is an AI-powered, intraoperative imaging and navigation system from Body Vision Medical that transforms 2D C-arm images into real-time 3D for precise peripheral lung biopsy and intervention. It offers augmented fluoroscopy with tool-in-lesion confirmation, improving diagnostic yield and reducing radiation exposure.

Reviews & Opinions

No web reviews on file yet for Body Vision Medical. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Body Vision Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Body Vision Medical →

View all on YouTube

Press & Coverage

PR Newswire
Body Vision Medical Expands Access to AI Tomou00ae with Major LungVisionu00ae Platform Upgrade
Body Vision Medical announced a significant upgrade to its LungVision platform, providing universal access to AI Tomo imaging, which allows for 3D views from 2D imaging systems during bronchoscopy procedures. This advancement aims to improve early and accurate lung cancer diagnosis globally by making the technology compatible with nearly any fluoroscopic C-arm model.
2025-08
ParagonCare
Body Vision Medical Receives Regulatory Approval for LungVisionu00ae in Australia, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
Body Vision Medical's LungVision AI-driven advanced imaging system has received regulatory approval from the Therapeutic Goods Administration (TGA) in Australia. This approval, in partnership with ParagonCare, aims to provide hospitals and clinics in Australia and New Zealand with access to state-of-the-art AI-driven imaging solutions for lung cancer diagnosis.
2025-03
PR Newswire
Body Vision Medical Receives Pre-Market Approval for LungVisionu00ae in Singapore, Advancing AI-Powered Imaging for Early Lung Cancer Diagnosis
Body Vision Medical's LungVision advanced imaging platform has received Pre-Market Approval from Singapore's Health Sciences Authority (HSA), enabling its full commercialization in Singapore. This milestone aims to improve early and accurate diagnosis of lung cancer in a region where it is a significant health concern.
2025-08
PR Newswire
Body Vision Medical Receives Regulatory Approval for LungVisionu00ae in India, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
Body Vision Medical has received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India for its LungVision AI-powered advanced imaging system. This approval is a major step in transforming lung cancer care in India, where late diagnosis is common.
2025-09
PR Newswire
Body Vision Medical Receives Innovative Technology Contract from Vizient for LungVisionu00ae
Body Vision Medical's LungVision AI-driven image guidance system has been awarded an Innovative Technology contract from Vizient, Inc., a leading healthcare performance improvement company. This contract signifies LungVision's unique qualities that can improve the healthcare industry, making it more accessible to Vizient's provider customers.
2024-07
Body Vision Medical (Publications)
Updates in Bronchoscopic Diagnostics and Therapeutics: Late-Breaking Scientific Abstracts
This publication highlights updates in bronchoscopic diagnostics and therapeutics, including late-breaking scientific abstracts related to the field. It is part of Body Vision Medical's collection of peer-reviewed research on LungVisionu00ae.
2025-10
Body Vision Medical (Publications)
Radiation in the Bronchoscopy Suite: One Center's Experience With Navigational Bronchoscopy and a Review of the Literature
This article details one center's experience with navigational bronchoscopy and reviews existing literature on radiation exposure in the bronchoscopy suite. It is a peer-reviewed publication found on Body Vision Medical's website.
2025-01
PR Newswire
Body Vision Closing $20 Million in Series C Funding
Body Vision Medical, a company specializing in lung cancer diagnostics and treatment, closed $20 million in Series C funding. The funds are intended to streamline commercialization and manufacturing for their LungVisionu2122 2.0 Platform, which includes AI Tomography and fused imaging.
2019-09

Frequently Asked Questions

Body Vision Medical's flagship product is the LungVisionu2122 System, an AI-powered intraoperative imaging platform. It transforms standard 2D C-arm X-ray images into real-time 3D CT-like scans, enabling bronchoscopists to precisely navigate and biopsy small, peripheral lung lesions for early lung cancer diagnosis.
The LungVisionu2122 System received FDA clearance in May 2017, followed by the LungVision Tool in May 2018, and the LungVision 2.0 Platform in May 2019. The company also holds CE marking in Europe, demonstrating its commitment to global regulatory compliance and patient safety.
Body Vision Medical positions its LungVisionu2122 System as an affordable, low-cost solution with lower capital and per-case costs compared to traditional electromagnetic navigation bronchoscopy systems, robotics, and cone-beam CT. Its hardware-light design and compatibility with existing C-arms contribute to this cost-effectiveness, aiming to democratize access to advanced imaging.
Body Vision Medical provides comprehensive clinical training and ongoing case support after initial purchase to ensure successful system adoption and physician confidence. They also offer refresher training, education for new staff, and advanced training for experienced users, alongside various extended warranty service plans.
Body Vision Medical has forged numerous exclusive distribution agreements across Asia, Europe, and South America, aiming to expand into 60 new markets by 2025. They also partner with organizations like Healthcare Links to enhance access within group purchasing organizations and integrated delivery networks.
Founded in 2014, Body Vision Medical has successfully secured significant funding, including $8.5 million in 2018 and $20 million in Series C funding in 2019, demonstrating investor confidence. The company is actively expanding its global distribution network and continuously releasing software updates, indicating a strong growth trajectory and commitment to innovation.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.